Literature DB >> 17243160

Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein.

Marc A Weniger1, Stefan Gesk, Steve Ehrlich, José I Martin-Subero, Martin J S Dyer, Reiner Siebert, Peter Möller, Thomas F E Barth.   

Abstract

Gains or amplifications of the REL locus are frequently seen in primary mediastinal B-cell lymphoma (PMBL). In classical Hodgkin's lymphoma, genomic overrepresentation of REL correlated with nuclear REL protein accumulation. To investigate the correlation between REL gene copies and its RNA and protein expression in PMBL, we analyzed genomic, transcriptional, and protein levels in 20 PMBLs and the PMBL derived cell lines MedB-1 and Karpas1106P. We found gains/amplifications in 75% of the PMBLs by fluorescence in situ hybridization (FISH) and genomic REL overrepresentation in the PMBL lines. Three of the five PMBLs with amplifications displayed elevated REL transcripts, while only 3/10 PMBLs with gains showed increased REL transcripts by real-time PCR. One PMBL without gains displayed increased REL transcription. REL protein expression exhibited a variable pattern across the PMBLs except for a single case that was completely negative by immunohistochemistry despite having gained REL. Although transcript levels were generally low and nuclear REL staining was weak in the lymphoma cell lines, these nevertheless exhibited high NF-kappaB activation. By fluorescence immunophenotyping and interphase cytogenetics as a tool for investigation of neoplasms, genomic gains/amplifications of REL significantly correlated with nuclear REL expression (P < 0.05). In conclusion, the frequent genomic overrepresentation of REL in PMBL does not necessarily trigger an increased transcription/translation of REL. However, combined genomic and protein analysis revealed a significant association of gained REL and nuclear REL accumulation at the single cell level. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17243160     DOI: 10.1002/gcc.20420

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  22 in total

1.  Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.

Authors:  Ilske Oschlies; Birgit Burkhardt; Itziar Salaverria; Andreas Rosenwald; Emanuele S G d'Amore; Monika Szczepanowski; Karoline Koch; Martin L Hansmann; Harald Stein; Peter Möller; Alfred Reiter; Martin Zimmermann; Angelo Rosolen; Reiner Siebert; Elaine S Jaffe; Wolfram Klapper
Journal:  Haematologica       Date:  2010-10-22       Impact factor: 9.941

2.  CAPERalpha is a novel Rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent Rel/NF-kappaB oncoprotein v-Rel.

Authors:  Jui Dutta; Gaofeng Fan; Céline Gélinas
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

Review 3.  Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies.

Authors:  Pier Luigi Zinzani; Pier Paolo Piccaluga
Journal:  Curr Oncol Rep       Date:  2011-10       Impact factor: 5.075

4.  Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling.

Authors:  Karen E Deffenbacher; Javeed Iqbal; Warren Sanger; Yulei Shen; Cynthia Lachel; Zhongfeng Liu; Yanyan Liu; Megan S Lim; Sherrie L Perkins; Kai Fu; Lynette Smith; James Lynch; Louis M Staudt; Lisa M Rimsza; Elaine Jaffe; Andreas Rosenwald; German K Ott; Jan Delabie; Elias Campo; Randy D Gascoyne; Mitchell S Cairo; Dennis D Weisenburger; Timothy C Greiner; Thomas G Gross; Wing C Chan
Journal:  Blood       Date:  2012-02-28       Impact factor: 22.113

Review 5.  Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.

Authors:  Kian-Huat Lim; Yibin Yang; Louis M Staudt
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

6.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

7.  High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma.

Authors:  Saloua Toujani; Philippe Dessen; Nathalie Ithzar; Gisèle Danglot; Catherine Richon; Yegor Vassetzky; Thomas Robert; Vladimir Lazar; Jacques Bosq; Lydie Da Costa; Christine Pérot; Vincent Ribrag; Catherine Patte; Jöelle Wiels; Alain Bernheim
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

Review 8.  [Lymph node pathology - an update].

Authors:  S Hartmann; M L Hansmann
Journal:  Pathologe       Date:  2013-02       Impact factor: 1.011

9.  Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family.

Authors:  Gaofeng Fan; Yongjun Fan; Nupur Gupta; Isao Matsuura; Fang Liu; Xiao Zhen Zhou; Kun Ping Lu; Céline Gélinas
Journal:  Cancer Res       Date:  2009-05-19       Impact factor: 12.701

10.  c-Rel gain in B cells drives germinal center reactions and autoantibody production.

Authors:  Maike Kober-Hasslacher; Hyunju Oh-Strauß; Dilip Kumar; Valeria Soberon; Carina Diehl; Maciej Lech; Thomas Engleitner; Eslam Katab; Vanesa Fernández-Sáiz; Guido Piontek; Hongwei Li; Björn Menze; Christoph Ziegenhain; Wolfgang Enard; Roland Rad; Jan P Böttcher; Hans-Joachim Anders; Martina Rudelius; Marc Schmidt-Supprian
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.